News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
214,512 Results
Type
Article (20215)
Company Profile (103)
Press Release (194187)
Multimedia
Podcasts (55)
Webinars (20)
Section
Business (71427)
Career Advice (844)
Deals (9056)
Drug Delivery (94)
Drug Development (18844)
Employer Resources (149)
FDA (3435)
Job Trends (6149)
News (95409)
Policy (7102)
Tag
2025 Best Places to Work (13)
2026 Best Places to Work (18)
2027 BioCapital Standard (3)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (4)
40 Under 40 (3)
Academia (1548)
Academic (2)
Accelerated approval (30)
ADA (17)
Adcomms (18)
Allergies (53)
Alliances (17380)
ALS (90)
Alzheimer's disease (810)
Antibody-drug conjugate (ADC) (225)
Approvals (3710)
Artificial intelligence (470)
ASCO (104)
Autoimmune disease (167)
Automation (42)
Bankruptcy (53)
Belgium (14)
Best Places to Work (4886)
BIO (33)
Biologics (46)
BIOSECURE Act (12)
Biosimilars (100)
BioSpace Insights (131)
Biotechnology (53)
Bispecific (24)
Bladder cancer (60)
Brain cancer (24)
Breast cancer (299)
Cancer (2222)
Cardiovascular disease (238)
Career advice (787)
Career pathing (50)
CAR-T (138)
CDC (28)
CDMO (73)
Celiac Disease (2)
Cell therapy (384)
Cervical cancer (24)
Clinical research (16334)
Collaboration (1198)
Commercialization (25)
Company closure (1)
Compensation (269)
Complete response letters (28)
COVID-19 (1032)
CRISPR (74)
CRO (5)
C-suite (959)
Cystic fibrosis (65)
Data (3473)
Decentralized trials (3)
Denatured (33)
Depression (68)
Dermatology (86)
Diabetes (228)
Diagnostics (2726)
Digital health (30)
Diversity (10)
Diversity, equity & inclusion (37)
Drug discovery (261)
Drug pricing (58)
Drug shortages (7)
Duchenne muscular dystrophy (109)
Earnings (16497)
Editorial (25)
Employer branding (25)
Employer resources (131)
ESMO (103)
Events (33039)
Executive appointments (760)
Eye disease (9)
FDA (4859)
Fibrodysplasia Ossificans Progressiva (5)
Fragile X (5)
Friedreich's ataxia (14)
Frontotemporal dementia (9)
Funding (1142)
Gene editing (132)
Generative AI (46)
Gene therapy (286)
GLP-1 (412)
Government (1466)
Guidances (137)
Healthcare (5082)
Hematology (78)
HIV (75)
Huntington's disease (35)
Idiopathic pulmonary fibrosis (3)
IgA nephropathy (47)
Immunology and inflammation (92)
Immuno-oncology (37)
Indications (94)
Infectious disease (1188)
Inflammatory bowel disease (104)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (103)
Interviews (128)
IPO (3666)
IRA (17)
Job creations (1319)
Job search strategy (651)
JPM (28)
Kidney cancer (6)
Kidney disease (57)
Labor market (119)
Layoffs (221)
Leadership (31)
Legal (1187)
Licensing (57)
Liver cancer (30)
Longevity (29)
Lung cancer (272)
Lung diease (11)
Lymphoma (201)
Machine learning (36)
Management (47)
Manufacturing (585)
Marketing (9)
MASH (48)
Medical affairs (5)
Medical device (2770)
Medtech (2848)
Melanoma (64)
Mergers & acquisitions (6046)
Metabolic disorders (533)
Middle East (1)
mRNA (106)
Multiple sclerosis (118)
Multispecific (1)
NASH (9)
Netherlands (26)
Neurodegenerative disease (197)
Neuropsychiatric disorders (32)
Neuroscience (1522)
Neurotech (2)
NextGen: Class of 2026 (2084)
Non-profit (1717)
Now hiring (95)
Obesity (243)
Opinion (163)
Ovarian cancer (74)
Pain (112)
Pancreatic cancer (87)
Parkinson's disease (150)
Partnered (22)
Patents (153)
Patient advocacy (3)
Patient recruitment (227)
Patient selection (22)
Peanut (19)
People (29284)
Peptides (18)
Pharmaceutical (21)
Pharmacy benefit managers (3)
Phase 1 (4759)
Phase 2 (6721)
Phase 3 (6437)
Pipeline (4468)
Policy (139)
Postmarket research (557)
Preclinical (2692)
Press Release (61)
Prostate cancer (116)
Psychedelics (34)
Radiopharmaceuticals (102)
Rare diseases (443)
Real estate (2571)
Recruiting (62)
Regenerative medicine (13)
Regulatory (6475)
Reports (54)
Research institute (1353)
Resumes & cover letters (110)
Rett syndrome (10)
RNA editing (14)
RSV (51)
Saudi Arabia (1)
Schizophrenia (73)
Series A (227)
Series B (136)
Series C (1)
Service/supplier (6)
Sickle cell disease (54)
Special edition (16)
Spinal muscular atrophy (63)
Sponsored (22)
Startups (2059)
State (1)
Stem cells (1)
Stomach cancer (7)
Substance use disorders (4)
Supply chain (50)
Switzerland (8)
Tariffs (18)
Tax incentives (1)
The Weekly (22)
Vaccines (396)
Venture capital (121)
Weight loss (146)
Wet AMD (4)
Women's health (86)
Worklife (22)
Date
Today (35)
Last 7 days (232)
Last 30 days (1200)
Last 365 days (10610)
2026 (9755)
2025 (9644)
2024 (11359)
2023 (12947)
2022 (15519)
2021 (17634)
2020 (16242)
2019 (14944)
2018 (10797)
2017 (10276)
2016 (10148)
2015 (10838)
2014 (7985)
2013 (6918)
2012 (7346)
2011 (7526)
2010 (7014)
Location
Africa (335)
Alabama (38)
Alaska (4)
Arizona (126)
Arkansas (4)
Asia (12113)
Australia (2093)
California (5148)
Canada (1528)
China (557)
Colorado (272)
Connecticut (161)
Delaware (235)
Europe (31673)
Florida (724)
Georgia (153)
Hawaii (3)
Idaho (12)
Illinois (364)
India (60)
Indiana (404)
Iowa (21)
Japan (310)
Kansas (53)
Kentucky (17)
Louisiana (14)
Maine (12)
Maryland (457)
Massachusetts (4089)
Michigan (160)
Minnesota (253)
Mississippi (6)
Missouri (62)
Montana (6)
Nebraska (10)
Nevada (58)
New Hampshire (17)
New Jersey (1504)
New Mexico (19)
New York (1595)
North Carolina (791)
North Dakota (12)
Northern California (2827)
Ohio (175)
Oklahoma (14)
Oregon (28)
Pennsylvania (815)
Puerto Rico (15)
Rhode Island (20)
South America (394)
South Carolina (16)
Southern California (1858)
Tennessee (102)
Texas (762)
United States (18641)
Utah (106)
Vermont (1)
Virginia (139)
Washington D.C. (33)
Washington State (419)
West Virginia (1)
Wisconsin (116)
Wyoming (1)
214,512 Results for "myovant sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Sumitovant Biopharma Completes Acquisition of Myovant Sciences
Sumitovant Biopharma Ltd. (“Sumitovant”) and Myovant Sciences Ltd. (“Myovant”) announced today that Sumitovant has successfully completed its acquisition of Myovant originally announced October 23, 2022.
March 10, 2023
·
5 min read
Funding
OrbiMed raises two new life sciences funds worth $3B with one aiming for Asia
The sixth cycle of OrbiMed’s Asia Partners fund included one with more than $1 billion earmarked for life science companies based on the Eastern continent.
October 16, 2026
·
1 min read
·
Tristan Manalac
Eye disease
Kodiak Sciences’ stock soars 166% after 2 assets match Eylea in Phase 3 trial
Kodiak Sciences will head to regulators with one of the candidates, an anti-VEGF antibody called zenkuda, after the late-stage results.
September 28, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
Conexeu Sciences Appoints Life Sciences Veteran Daniel M. Bradbury as Chairman of the Board of Directors
November 19, 2026
·
9 min read
Immunology and inflammation
AB Science ends 3 studies in multiple sclerosis, other immune conditions
The trials, which were testing the tyrosine kinase inhibitor masitinib, had previously been paused. AB Science’s decision not to resume them was a matter of prioritization, not safety, the biotech said.
July 13, 2026
·
2 min read
·
Tristan Manalac
Business
Myovant Sciences Cancels Second Quarter Earnings Conference Call
Myovant Sciences (NYSE: MYOV) (“Myovant”) today announced the cancellation of its earnings conference call for the quarter ended September 30, 2022 that had originally been scheduled for October 26, 2022 at 5:00 p.m. Eastern Time.
October 24, 2022
·
1 min read
Biotech Bay
Myovant Sciences to Participate at Upcoming September 2022 Investor Conferences
Myovant Sciences announced that David Marek, Chief Executive Officer of Myovant Sciences, Inc., and Uneek Mehra, Chief Financial and Business Officer, will participate in the following upcoming investor conferences.
September 2, 2022
·
2 min read
Press Releases
IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes
October 7, 2026
·
2 min read
Press Releases
Noveris Health Sciences Announces Commencement of Strategic Review Process
November 16, 2026
·
5 min read
Press Releases
TriSalus Life Sciences Reports Third Quarter 2026 Results
November 10, 2026
·
15 min read
1 of 21,452
Next